Skip to content
MDT Medtronic PLC NYSE
81.46 USD -2.49% -2.08
OPEN 82.77
DAY RANGE 83.50 - 81.02
52 WEEK RANGE 101.39 - 75.77
Interactive Brokers Logotype

Buy MDT stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 108.4B
Enterprise value 108.4B
Trailing pe 28.886526
Forward pe 14.703971
Peg ratio 14.703971
Price to sales ttm 3.471604
Price to book mrq 2.1050727
Enterprise to revenue 3.471
Enterprise to ebitda 12.71


Fiscal year ends 2023-04-28
Most recent quarter 2023-01-31
Profit margin 0.120340005
Operating margin 0.1867
Return on assets ttm 0.04006
Return on equity ttm 0.0725
Income statement
Revenue ttm 31.2B
Revenue per share ttm 23.482
Quarterly revenue growth 0.018721160184575
Gross profit ttm 21.5B
Ebitda 8.8B
Net income to common ttm 3.8B
Diluted eps ttm 2.82
Balance sheet
Total debt mrq 28.1B
Total debt to equity mrq 1.0445632798574
Current ratio mrq 2.395
Book value per share mrq 38.697
Cash flow
Operating cash flow ttm 6B
Levered free cash flow ttm 3.8B

Stock statistics

Shares outstanding 1.3B
Float shares 1.3B
Avg 10 volume 6.5M
Avg 30 volume 6.4M
Shares short 10.7M
Short ratio 1.71
Short percent of shares outstanding 0.008
Percent held by insiders 0.00093999994
Percent held by institutions 0.84540004

Stock price summary

Fifty two week low 75.77
Fifty two week high 100.62
Fifty two week change -22.944
Day 50 ma 84.7984
Day 200 ma 83.6321

Dividends and splits

Forward annual dividend rate 2.76
Forward annual dividend yield 0.0339
Trailing annual dividend rate 2.72
Trailing annual dividend yield 0.033390621163761
5 year average dividend yield 2.28
Payout ratio 0.96449995
Dividend date 2023-04-14
Ex dividend date 2023-06-22
Last split factor 2-for-1 split
Last split date 1999-09-27

Medtronic (MDT) company profile

Medtronic plc. (NYSE: MDT) is a medical technology and services company that develops, manufactures and markets medical devices and technologies. The company serves hospitals, physicians, clinicians and patients in over 150 countries globally. It operates under the segments of Cardiovascular Portfolio, Neuroscience Portfolio, Medical-Surgical Portfolio, and Diabetes Operating Unit.